The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 02, 2024

Filed:

Apr. 19, 2022
Applicant:

Gilead Sciences, Inc., Foster City, CA (US);

Inventors:

Megan K. Armstrong, San Francisco, CA (US);

James S. Cassidy, San Francisco, CA (US);

Elbert Chin, San Mateo, CA (US);

Chienhung Chou, Dublin, CA (US);

Jeromy J. Cottell, Redwood City, CA (US);

Chao-I Hung, San Mateo, CA (US);

Kavoos Kolahdouzan, San Francisco, CA (US);

David W. Lin, Berkeley, CA (US);

Michael L. Mitchell, Castro Valley, CA (US);

Ezra Roberts, San Francisco, CA (US);

Scott D. Schroeder, Union City, CA (US);

Nathan D. Shapiro, Belmont, CA (US);

James G. Taylor, Burlingame, CA (US);

Rhiannon Thomas-Tran, San Jose, CA (US);

Nathan E. Wright, San Diego, CA (US);

Zheng-Yu Yang, Palo Alto, CA (US);

Assignee:

GILEAD SCIENCES, INC., Foster City, CA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07D 405/14 (2006.01); A61K 31/437 (2006.01); A61K 31/4439 (2006.01); A61K 31/497 (2006.01); A61K 31/506 (2006.01); A61K 31/5377 (2006.01); A61K 31/675 (2006.01); C07D 401/08 (2006.01); C07D 401/10 (2006.01); C07D 401/14 (2006.01); C07D 409/14 (2006.01); C07D 417/14 (2006.01); C07D 471/04 (2006.01); C07D 491/048 (2006.01); C07D 493/08 (2006.01); C07D 493/10 (2006.01); C07F 9/6558 (2006.01);
U.S. Cl.
CPC ...
C07D 405/14 (2013.01); A61K 31/437 (2013.01); A61K 31/4439 (2013.01); A61K 31/497 (2013.01); A61K 31/506 (2013.01); A61K 31/5377 (2013.01); A61K 31/675 (2013.01); C07D 401/08 (2013.01); C07D 401/10 (2013.01); C07D 401/14 (2013.01); C07D 409/14 (2013.01); C07D 417/14 (2013.01); C07D 471/04 (2013.01); C07D 491/048 (2013.01); C07D 493/08 (2013.01); C07D 493/10 (2013.01); C07F 9/65586 (2013.01);
Abstract

The present disclosure provides GLP-1R agonists, and compositions, methods, and kits thereof. Such compounds are generally useful for treating a GLP-1R mediated disease or condition in a human.


Find Patent Forward Citations

Loading…